The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium.

about

The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium.

Item

http://www.wikidata.org/entity/Q47581193

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@en

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@nl

type

Item

label

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@en

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@nl

prefLabel

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@en

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@nl

P1476

The BCR-ABL1-negative myelopro ...... the therapeutic armamentarium.

@en

P2093

Martin Griesshammer

http://www.w3.org/2001/XMLSchema#string

Parvis Sadjadian

http://www.w3.org/2001/XMLSchema#string

P2860

Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms

Pathogenesis of myeloproliferative neoplasms

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

P304

1929-1938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1404574

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29134817

http://www.w3.org/2001/XMLSchema#string